Semaglutide has emerged as a promising treatment for type 2 diabetes. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and reducing glucagon production. Moreover, semaglutide possesses potential effects beyond diabetes management, including weight loss and possibly improv

Semaglutide has gained significant traction in recent years as a medication for treating type 2 diabetes and obesity. This potent glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting insulin secretion . Understanding how semaglutide functions is essential for indivi